HCC
MJN

Hirtle Callaghan & Co’s Mead Johnson Nutrition Company MJN Stock Holding History

Hirtle Callaghan & Co’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-458
Closed -$40K – 190
2017
Q1 		$40K Hold
458
– – 0.01% 93
2016
Q4 		$32K Sell
458
-340
-43% -$25.3K 0.01% 91
2016
Q3 		$63K Hold
798
– – 0.01% 125
2016
Q2 		$72K Sell
798
-335
-30% -$28.4K 0.01% 104
2016
Q1 		$95K Sell
1,133
-275
-20% -$20.5K 0.02% 115
2015
Q4 		$111K Sell
1,408
-2,215
-61% -$174K 0.03% 84
2015
Q3 		$255K Hold
3,623
– – 0.04% 53
2015
Q2 		$327K Buy
+3,623
New +$349K 0.11% 45

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Hirtle Callaghan & Co's MJN Position: Q2 2017 in Review

Hirtle Callaghan & Co sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 458 shares — an estimated $40K sold.

Hirtle Callaghan & Co first reported a position in MJN in Q2 2015 and held it in 8 quarters. The position peaked at $327K in Q2 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Hirtle Callaghan & Co reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 458 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $40K.
  • Hirtle Callaghan & Co first reported a position in Mead Johnson Nutrition Company in Q2 2015 and held it in 8 quarters.
  • Hirtle Callaghan & Co's Mead Johnson Nutrition Company position peaked at $327K in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2017, filed 4 Aug 2017.